Dexeryl

DEVICE4 trials

Sponsors

Poitiers University Hospital, Centre Leon Berard, Relife Italia S.r.l., Pierre Fabre Medicament

Conditions

Actinic KeratosesColorectal CancerDermatitis, Radiation-InducedEpidermal Growth Factor Receptor InhibitorHead and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerRadiodermatitisSurgery Scheduled

Phase 2

Evaluating the Effectiveness of Dermal Analgesia Provided by the Application of Lidocaine and Prilocaine Cream 5% on the Puncture Site of Axillary Blocks

CompletedNCT01673542

Poitiers University HospitalSurgery Scheduled

Start: 2012-08-31Updated: 2016-10-12

Phase 4

Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

CompletedNCT04875026

Pierre Fabre MedicamentActinic Keratoses

Start: 2021-02-16End: 2022-01-31Updated: 2022-09-19

Unknown Phase

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

CompletedNCT03421912

Centre Leon BerardColorectal Cancer, Epidermal Growth Factor Receptor Inhibitor, Head and Neck Squamous Cell Carcinoma +1

Start: 2018-02-16End: 2021-05-11Updated: 2021-07-09

Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.

CompletedNCT04483856

Relife Italia S.r.l.Dermatitis, Radiation-Induced, Radiodermatitis

Start: 2020-11-02End: 2023-02-16Updated: 2025-05-15